Zusammenfassung
Komplikationen in der Sterilitätsdiagnostik und -therapie gelten gemeinhin als äußerst schwerwiegend, da die zu Behandelnden mit Kinderwunsch landläufig nicht als „Kranke“ und eine invasive Diagnostik als nicht erforderlich betrachtet werden. Bei den Komplikationen in der Diagnostik handelt es sich um Organverletzungen mit Blutungs- und Infektionskomplikationen, aszendierende Infektionen und selten um Spätkomplikationen wie Ileus und Inkarzerationen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Anderson K, Haxton M, Banham S, Black W (1988) Unilateral effusion as the presenting feature of ovarian hyperstimulation syndrome. Scott Med J 33: 338–339
Balasch J, Carmona F, Llach J, Arroyo V, Jove I, Vanrell JA (1990) Severe ovarian hyperstimulation syndrome: role of peripheral vasoldilatation. Human Reprod 5 /3: 348–513.
Balasch J, Arroyo V, Carmona F, Llach J, Jimenez W, Paare JC, Vanrell JA (1991) Fertil Steril 56 /6: 1077–1083
Benifla JL, Conrad J, Naouri M et al. (1994) Ovarian hyperstimulation syndrome and thrombosis. Apropos of a case of thrombosis of the internal jugular vein. J Gynecol Ob-stet Biol Reprod Paris 23: 778–783
Ben-Refael Z, Orvieto R (1996) The Role of Interleukin-2 in ovarian hyperstimulation syndrome. IXth world congress on human reproduction. Philadelphia, Abstr 271
Bider D, Menashe Y, Oelsner G, Serr DM, Mashiach S, Ben-Rafael Z (1989) Ovarian hyper-stimulation syndrome due to exogenous gonadotropin administration. Acta Obstet Gynecol Scand 68 /6: 511–514
Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS (1995) Diagnosis prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 102 /10: 767–772
Bung P, Plath H, Pried G, Krebs D (1996) Ileus in der Spätschwangerschaft–Folge der Follikelpunktion im Rahmen der In-vitro-Fertilisation? Geburtshilfe Freuenheilkd 56: 252–253
Cornwalls CM, Skinner SL, Nayudu PL, Lopata A, Thatcher RL, Yeung SP, Witworth JA (1990) Human Reprod 5 /4: 413–417
Crouet H, Herlicoviez M, Rouffet P, Mandard JC, Levy G (1985) Luteinized cystic hyperplasia of the ovaries in normal pregnancy. Diagnostic and nosological problems. J Gynecol Obstet Reprod Paris 14 /5: 613–618
Delbaere A, Bergman PJ, Grvy-Decoster C, Staroukine M, Englert Y (1994) Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Fertil Steril 62 /4: 731–737
Derkx FH, Schalekamp MA (1988) Human prorenin: pathophysiology and clinical implication. Clin Exp Hypertens 10 /6: 1213–1225
Dicker D, Ashkenazi J, Feldberg D, Levy T, Dekel A, Ben-Rafael Z (1993) Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilisation and embryo transfer. Fertil Steril 59 /6: 1313–1315
Fakih H, Bello S (1992) Ovarian cyst aspiration: a therapeutic approach to ovarian hyper-stimulation syndrome. Fertil Steril 58 /4: 829–832
Fukaya T, Chida S, Terada Y, Funayama Y, Yajima A (1994) Treatment of severe ovarian hyperstimulation syndrome by ultrafiltration and reinfusion of ascitic fluid. Fertil Steril 61/ 3: 561–564
Goldschmit R, Elchalal U, Zalel Y, Barash A, Borenstein R, Insler V (1993) Hypovolemic shock as a presenting sign of severe ovarian hyperstimulation syndrome following in vitro fertilisation and embryo transfer (IVF-ET). Assist Reprod Gene 10 /7: 480–482
Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Ash RH (1995) Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril 63 /2: 268–272
Goshen R, Lavy Y, Hochner-Celnikier H, Milwidsky A (1992) Third trimester torsion of persistent ovarian cyst following ovarian hyperstimulation–an unusual cause of preterm labor. Gynecol Obstet Invest 33 /4: 244–245
Granat M, Evron S, Navot D (1981) Pregnancy in heterotopic fallopian tube and unilateral ovarian hyperstimulation. Acta Obstet Gynecol Scand 60 /2: 215–217
Hsieh M, Tsao TC, Cheng PJ (1994) Ovarian hyperstimulation syndrome with minimal ascites and massive pleural effusion: report of a case. J Formos Med Assoc 93 /10: 882–884
Hulinsky I, Smith HC (1995) External jugular vein thrombosis: a complication of the ovarian hyperstimulation syndrome. Med J Aus 162 /2: 102–103
Inbar OJ, Levran D, Mashiach S, Dor J (1994) Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome. Fertil Steril 62 /5: 1075–1076
Iwabe T, Harada T, Tuzaki T, Terakawa N (1994) Laparoscopic unwinding of adnexal torsion caused by ovarian hyperstimulation. Human Reprod 9 /12: 2350–2352
Kaaja R, Siegberg R, Tiitinen A, Koskomies A (1989) Severe ovarian hyperstimulation syndrome and deep venous thrombosis. Lancet 2 /8670: 1043
Katz Z, Lancet M, Borenstein R, Chemke J (1984) Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. Int J Fertil 29 /3: 186–188
Kligman I, Noyes N, Benadiva CA, Rosenwaks Z (1995) Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilisation. Fertil Steril 63 /3: 673–676
Kodama H, Fukuda J, Matsui T, Shimizu Y, Tanaka T (1995) Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome (OHSS) who actually developed thromboembolism. Fertil Steril 64 /6: 1207–1209
Lanzone A, Fulghesu AM, Villa P et al. (1994) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in ovarian disease gonadotropin hyperstimulated cycles. Fertil Steril 62 /1: 35–41
Lindner C, Braendle W, Kohler S, Bettendorf G (1989) Zunahme des Ovariellen Überstimulationssyndroms nach GnRH-analoga/HMG Therapie. Geburtshilfe Frauenheilkd 49/ 4: 337–344
Lindner C, Braendle W, Kohler S, Bettendorf G (1989) Vermehrte Häufigkeit des Ovarellen Überstimulationssyndromes nach GnRH-Analoga/HMG Therapie. Geburtshilfe Frauenheilkd 49 /4: 337–344
Lipitz S, Ben-Rafael Z, Bider D, Shalev J, Mashiach S (1991) Quintuplet pregnancy and third degree ovarian hyperstimulation despite withholding human chorionic gonadotropin. Hum Reprod 6 /10: 1478–1479
Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z (1990) Adnexal torsion of hyperstimulated ovaries in prenancies after gonadotropin therapy. Fertil Steril 53 /1: 76–80
McClure N, Leya J, Radwanska E, Rawlins R, Haning RV Jr (1992) Luteal phase support and severe ovarian hyperstimulation syndrome. Hum Reprod 7 /6: 758–764
Mills MS, Eddowes HA, Fox R, Wardle G (1992) Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome: Hum Reprod 7 /3: 370–371
Moran L, Ortega E, Fiorelli S, Murillo A, Zarate A (1992) Treatment and prevention of the ovarian hyperstimulation syndrome. Ginecol Obstet Mex 60: 4–7
Morgan H, Paredes RA, Lachelin GC (1983) Severe ovarian hyperstimulation after clomiphene citrate in a hypothyroid patient. Br J Obstet Gynaecol 90 /1: 977–982
Morris RS, Wong IL, Kirkma E, Gentschein E, Paulson RJ (1995) Inhibition of ovarian derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum Reprod 10 /6: 1355–1358
Morris RS, Miller C, Jacobs L, Miller K (1995) Conservative management of ovarian hyper-stimulation syndrome. J Reprod Med 40 /10: 711–714
Mukherjee T, Copperman AB, Sandler B, Bustillo M, Grunfeld L (1995) Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in-vitro fertilisation and embryo transfer. Fertil Steril 64 /3: 641–643
Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ (1988) Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 159 /1: 210–217
Navot D, Bergh PA, Laufer N (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58 /2: 249–261
Neulen J, Dvorak HF, Yeo KT, Breckwoldt M (1996) VEGF/VPF-Gene expression and production by human granulosa cells: clinical implication. IXth World congress on human reproduction, Philadelphia, Abstr 287
Ng E, Leader A, Claman P, Domingo M, Spence JE (1995) Intravenous albumin does not prevent the development of severe ovarian hyperstimulation in an in-vitro programm. Human Reprod 10 /4: 807–810
Perez-Ocharan M, Serviere-Zaragoza C, Barron-Vallejo J, Alvarado-Duran A, Kably-Ambe A (1995) Pyo-ovary as a complication of transvaginal follicular aspiration. Ginecol Obstet Mex 63: 102–103
Pryor RA, Wiczyk HP, O’Shea DL (1995) Adnexal infarcation after conservative surgical management of torsion of hyperstimulated ovary. Fertil Steril 63/6: 13 344–13 346
Robertson D, Selleck K, Suikkari AM, Hurley V, Moohan J, Healy D (1995) Urinary vascular endothelial growth factor concentration in women undergoing gonadotropin treatment. Human Reprod 10 /9: 1478–2482
Rosenberg ME, Mckenzie JK, Mckenzie IM, Junaid A, Tagatz GE (1994) Increased ascetic fluid protein in the ovarian hyperstimulation syndrome. Am J Kidney Dis 23 /3: 427–429
Rotmensch S, Scommegna A (1989) Spontaneous ovarian hyperstimulation syndrome associated with hypothyroidism. Am Obstet Gynecol 160 /5: 1220–1222
Schenker JG, Weinstein D (1978) The ovarian hyperstimulation syndrome: a current survey. Fertil Steril 30 /3: 255–268
Shalev E, Peleg D (1993) Laparoscopic treatment of adnexal torsion. Surg Gynecol Obstet 176 /5: 448–450
Shalev E, Giladi Y, Matilsky M, Ben-Amin M (1995) Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilisation patients receiving intravenous albumin: a prospective study. Hum Reprod 10 /6: 1373–1376
Shalex E, Geslevich Y, Ben-Ami M (1994) Induction of pre-ovulatory luteinizing hormone surge by gonadotropin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome. Reprod 9 /3: 417–419
Sher G, Salem R, Reinman M, Dodge S, Zouves C, Knutzen V (1993) Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilisation and embryo transfer. Obstet Gynecol 81 /6: 1009–1011
Shristav P, Nadkarni P, Craft I (1994) Day care management of severe ovarian hyperstimulation syndrome avoids hospitalisation and morbidity. Hum Reprod 9 /5: 812–814
Shweiki D, Itin A, Gitay-Goren H, Keshet E (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91 /5: 2235–2243
Spendiani G, Mazzarella V, Tozzo C, Elli M, Casciani CU (1994) Autologous protein reinfusion in severe ovary hyperstimulation syndrome. J Am Coll Surg 179 /1: 25–28
Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC (1990) Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilisation. Hum Reprod 5 /8: 933–939
Tan SL, Balen A, El-Hussein E, Campbell S, Jacobs HS (1992) The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in vitro fertilisation: a prospective randomised study. Fertil Steril 58 /2: 378–383
Tekay A, Martikainen H, Jouppila P (1995) Doppler patterns of the ovarian and uterine blood circulation in ovarian hyperstimulation syndrome. Ultrasound Obstet Gynecol 6/ 1: 50–53
Thill B, Rathat C, Akula A, Blaise M, Pourriat H (1994) Thromboembolic accidents in in-vitro-fertilisation. Ann Fr Anesth Reanim 13 /5: 726–729
Tollan A, Holst N, Forsdahl F, Fasnes HO, Oian P, Maltau JM (1990) Transcapillary Fluid dynamics during ovarian stimulation for in vitro fertilisation. Am J Obstet Gynecol 162/ 2: 554–558
Tulandi T, McInnes RA, Arronet GH (1984) Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin. Int J Fertil 29 /2: 113–117
Ugoscai G, Szollosi J, Godo G (1990) Simultaneous occurrence of bilateral extrauterine pregnancy and ovarian hyperstimulation syndrome following artificial heterologous insemination. Ory Hetil 131 /7: 363–365
Van der Merwe JP, Michell WL, Kruger TF (1988) Severe ovarian hyperstimulation after follicular aspiration. S Afr Med J 73 /7: 426–427
Van Hoorde GJ, Verhoeff A, Zeilmaker G (1992) Perforated appendicitis following transvaginal oocyte retrieval for in-vitro fertilisation and embryo transfer. Hum Reprod 7 /6: 850–851
Vauthier-Brouzes D, Lefebre G, Seebacher J, Wechsler B (1993) Internal jugular vein thrombosis during pregnancy after ovarian hyperstimulation for in vitro fertilisation. Contracept Fertil Sex 21 /1: 33–35
Wada I, Matson PL, Troup SA, Morroll D, Hunt I, Liebermann BA (1993) Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce in incidence of the condition. Br J Obstet Gynaecol 100 /3: 265–269
Wada I, Matson PL, Macnamae MC, Brinsden PR, Lieberman BA (1994) High ovarian response in Yoruba African women during ovulation induction of assisted conception. Hum Reprod 9 /6: 1077–1080
Waterstone JJ, Summers BA, Hoskins MC, Berry J, Parsons JH (1992) Ovarian hyperstimulation syndrome and deep cerebral venous thrombosis. Br J Obstet Gynaecol 99 /5: 439–440
Willms AB, Schlund JF, Meyer WR (1995) Endovaginal Doppler ultrasound in ovarian torsion: a case series. Ultrasound Obstet Gynecol 5 /2: 129–132
Yarali H, Fleige-Zahrada BG, Yuen BH, McComb (1993) The ascites in the ovarian hyper-stimulation syndrome does not originate from the ovary. Fertil-Steril 59 /3: 657–661
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bauer, O., Ludwig, M., Diedrich, K. (1998). Komplikationen in der Sterilitätstherapie und -diagnostik. In: Diedrich, K. (eds) Weibliche Sterilität. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58738-2_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-58738-2_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63704-9
Online ISBN: 978-3-642-58738-2
eBook Packages: Springer Book Archive